Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
Estimates of diagnosis-linked prescribing provided by Pfizer, Inc. (24). Each diagnosis was assigned to a diagnostic category by the authors. *Adjunctive treatment of epilepsy in adults older than age 12 years was the only U.S. Food and Drug Administrationapproved use of gabapentin during the time period shown.

Figure 1. Prescriptions for gabapentin, by diagnostic category.
Return to article